P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2006 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	21.9	-36.85%	🇺🇸 USA
Abbott Laboratories ABT	29.0	-16.39%	🇺🇸 USA
Medtronic MDT	23.5	-32.15%	🇮🇪 Ireland
Becton Dickinson BDX	28.7	-17.14%	🇺🇸 USA
Edwards Lifesciences EW	35.3	1.73%	🇺🇸 USA
Tandem Diabetes Care TNDM	-7.10	-120.50%	🇺🇸 USA
QuidelOrtho QDEL	-1.03	-102.98%	🇺🇸 USA
West Pharmaceutical Services WST	34.7	0.16%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.